DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.27 +0.07 (+0.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2026)

Updated

DiaMedica Therapeutics (DMAC) reported Operating Expenses of $10.5 million for Q2 2026, up 31.1% from $8.01 million a year earlier and up 0.2% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, DiaMedica Therapeutics' Operating Expenses came in at $39.23 million, up 24.7% year-over-year; for FY2025, it came in at $34.4 million, up 28.9% from FY2024.

  • Operating Expenses has increased for eight consecutive years, with a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $26.68 million in FY2024 (+25.5%), $21.27 million in FY2023 (+51.9%), $14 million in FY2022 (+2.6%) and $13.65 million in FY2021 (+7.5%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q1 2018.
  • Year over year, Operating Expenses has now increased in each of the last 15 quarters, with growth averaging 32.7% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q3 2023 (growth of 64.9%); the low point was Q4 2021 (a decline of 23.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $10.48 million (Q1 2026), $9.21 million (Q4 2025) and $9.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 10.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.50 Mn
Mar 31, 2026 10.48 Mn
Dec 31, 2025 9.21 Mn
Sep 30, 2025 9.03 Mn
Jun 30, 2025 8.01 Mn
Mar 31, 2025 8.14 Mn
Dec 31, 2024 8.42 Mn
Sep 30, 2024 6.88 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 5.74 Mn
Dec 31, 2023 5.85 Mn
Sep 30, 2023 5.16 Mn
Jun 30, 2023 4.74 Mn
Mar 31, 2023 5.52 Mn
Dec 31, 2022 3.97 Mn
Sep 30, 2022 3.13 Mn
Jun 30, 2022 3.36 Mn
Mar 31, 2022 3.54 Mn
Dec 31, 2021 3.25 Mn
Sep 30, 2021 3.42 Mn
API Access

DiaMedica Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DMAC&period=max&api_key=YOUR_API_KEY